Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM

Renato Goreshi, Joyce Okawa, Matt Rose, Rui Feng, Lela A. Lee, Christopher B. Hansen, Carolyn A. Bangert, M. Kari Connolly, Mark D. Davis, Jeff P. Callen, Nicole Fett, Steven S. Fakharzadeh, Jennie T. Clarke, Victoria P. Werth

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

To properly evaluate therapies for cutaneous dermatomyositis (DM), it is essential to administer an outcome instrument that is reliable, valid, and responsive to clinical change, particularly when measuring disease activity. The purpose of this study was to compare two skin severity DM outcome measures, the Cutaneous Disease and Activity Severity Index (CDASI) and the Cutaneous Assessment Tool-Binary Method (CAT-BM), with the Physician Global Assessment (PGA) as the "gold standard". Ten dermatologists evaluated 14 patients with DM using the CDASI, CAT-BM, and PGA scales. Inter- and intra-rater reliability, validity, responsiveness, and completion time were compared for each outcome instrument. Responsiveness was assessed from a different study population, where one physician evaluated 35 patients with 110 visits. The CDASI was found to have a higher inter- and intra-rater reliability. Regarding construct validity, both the CDASI and the CAT-BM were significant predictors of the PGA scales. The CDASI had the best responsiveness among the three outcome instruments examined. The CDASI had a statistically longer completion time than the CAT-BM by about 1.5 minutes. The small patient population may limit the external validity of the findings observed. The CDASI is a better clinical tool to assess skin severity in DM.

Original languageEnglish (US)
Pages (from-to)1117-1124
Number of pages8
JournalJournal of Investigative Dermatology
Volume132
Issue number4
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Skin Diseases
Reproducibility of Results
Dermatomyositis
Skin
Physicians
Population
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Goreshi, R., Okawa, J., Rose, M., Feng, R., Lee, L. A., Hansen, C. B., ... Werth, V. P. (2012). Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. Journal of Investigative Dermatology, 132(4), 1117-1124. https://doi.org/10.1038/jid.2011.440

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. / Goreshi, Renato; Okawa, Joyce; Rose, Matt; Feng, Rui; Lee, Lela A.; Hansen, Christopher B.; Bangert, Carolyn A.; Connolly, M. Kari; Davis, Mark D.; Callen, Jeff P.; Fett, Nicole; Fakharzadeh, Steven S.; Clarke, Jennie T.; Werth, Victoria P.

In: Journal of Investigative Dermatology, Vol. 132, No. 4, 04.2012, p. 1117-1124.

Research output: Contribution to journalArticle

Goreshi, R, Okawa, J, Rose, M, Feng, R, Lee, LA, Hansen, CB, Bangert, CA, Connolly, MK, Davis, MD, Callen, JP, Fett, N, Fakharzadeh, SS, Clarke, JT & Werth, VP 2012, 'Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM', Journal of Investigative Dermatology, vol. 132, no. 4, pp. 1117-1124. https://doi.org/10.1038/jid.2011.440
Goreshi, Renato ; Okawa, Joyce ; Rose, Matt ; Feng, Rui ; Lee, Lela A. ; Hansen, Christopher B. ; Bangert, Carolyn A. ; Connolly, M. Kari ; Davis, Mark D. ; Callen, Jeff P. ; Fett, Nicole ; Fakharzadeh, Steven S. ; Clarke, Jennie T. ; Werth, Victoria P. / Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. In: Journal of Investigative Dermatology. 2012 ; Vol. 132, No. 4. pp. 1117-1124.
@article{99d9a30acf924221beb9a367456d9388,
title = "Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM",
abstract = "To properly evaluate therapies for cutaneous dermatomyositis (DM), it is essential to administer an outcome instrument that is reliable, valid, and responsive to clinical change, particularly when measuring disease activity. The purpose of this study was to compare two skin severity DM outcome measures, the Cutaneous Disease and Activity Severity Index (CDASI) and the Cutaneous Assessment Tool-Binary Method (CAT-BM), with the Physician Global Assessment (PGA) as the {"}gold standard{"}. Ten dermatologists evaluated 14 patients with DM using the CDASI, CAT-BM, and PGA scales. Inter- and intra-rater reliability, validity, responsiveness, and completion time were compared for each outcome instrument. Responsiveness was assessed from a different study population, where one physician evaluated 35 patients with 110 visits. The CDASI was found to have a higher inter- and intra-rater reliability. Regarding construct validity, both the CDASI and the CAT-BM were significant predictors of the PGA scales. The CDASI had the best responsiveness among the three outcome instruments examined. The CDASI had a statistically longer completion time than the CAT-BM by about 1.5 minutes. The small patient population may limit the external validity of the findings observed. The CDASI is a better clinical tool to assess skin severity in DM.",
author = "Renato Goreshi and Joyce Okawa and Matt Rose and Rui Feng and Lee, {Lela A.} and Hansen, {Christopher B.} and Bangert, {Carolyn A.} and Connolly, {M. Kari} and Davis, {Mark D.} and Callen, {Jeff P.} and Nicole Fett and Fakharzadeh, {Steven S.} and Clarke, {Jennie T.} and Werth, {Victoria P.}",
year = "2012",
month = "4",
doi = "10.1038/jid.2011.440",
language = "English (US)",
volume = "132",
pages = "1117--1124",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM

AU - Goreshi, Renato

AU - Okawa, Joyce

AU - Rose, Matt

AU - Feng, Rui

AU - Lee, Lela A.

AU - Hansen, Christopher B.

AU - Bangert, Carolyn A.

AU - Connolly, M. Kari

AU - Davis, Mark D.

AU - Callen, Jeff P.

AU - Fett, Nicole

AU - Fakharzadeh, Steven S.

AU - Clarke, Jennie T.

AU - Werth, Victoria P.

PY - 2012/4

Y1 - 2012/4

N2 - To properly evaluate therapies for cutaneous dermatomyositis (DM), it is essential to administer an outcome instrument that is reliable, valid, and responsive to clinical change, particularly when measuring disease activity. The purpose of this study was to compare two skin severity DM outcome measures, the Cutaneous Disease and Activity Severity Index (CDASI) and the Cutaneous Assessment Tool-Binary Method (CAT-BM), with the Physician Global Assessment (PGA) as the "gold standard". Ten dermatologists evaluated 14 patients with DM using the CDASI, CAT-BM, and PGA scales. Inter- and intra-rater reliability, validity, responsiveness, and completion time were compared for each outcome instrument. Responsiveness was assessed from a different study population, where one physician evaluated 35 patients with 110 visits. The CDASI was found to have a higher inter- and intra-rater reliability. Regarding construct validity, both the CDASI and the CAT-BM were significant predictors of the PGA scales. The CDASI had the best responsiveness among the three outcome instruments examined. The CDASI had a statistically longer completion time than the CAT-BM by about 1.5 minutes. The small patient population may limit the external validity of the findings observed. The CDASI is a better clinical tool to assess skin severity in DM.

AB - To properly evaluate therapies for cutaneous dermatomyositis (DM), it is essential to administer an outcome instrument that is reliable, valid, and responsive to clinical change, particularly when measuring disease activity. The purpose of this study was to compare two skin severity DM outcome measures, the Cutaneous Disease and Activity Severity Index (CDASI) and the Cutaneous Assessment Tool-Binary Method (CAT-BM), with the Physician Global Assessment (PGA) as the "gold standard". Ten dermatologists evaluated 14 patients with DM using the CDASI, CAT-BM, and PGA scales. Inter- and intra-rater reliability, validity, responsiveness, and completion time were compared for each outcome instrument. Responsiveness was assessed from a different study population, where one physician evaluated 35 patients with 110 visits. The CDASI was found to have a higher inter- and intra-rater reliability. Regarding construct validity, both the CDASI and the CAT-BM were significant predictors of the PGA scales. The CDASI had the best responsiveness among the three outcome instruments examined. The CDASI had a statistically longer completion time than the CAT-BM by about 1.5 minutes. The small patient population may limit the external validity of the findings observed. The CDASI is a better clinical tool to assess skin severity in DM.

UR - http://www.scopus.com/inward/record.url?scp=84858297473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858297473&partnerID=8YFLogxK

U2 - 10.1038/jid.2011.440

DO - 10.1038/jid.2011.440

M3 - Article

VL - 132

SP - 1117

EP - 1124

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 4

ER -